Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Present at the BofA Securities 2025 Healthcare Conference Viatris Inc. (Nasdaq: VTRS), a global healthcare company, will present at the BofA Securities 2025 Healthcare Conference in Las Vegas, NV, on...

Key Takeaway: Viatris Inc. (Nasdaq: VTRS) has announced its upcoming presentation at the BofA Securities 2025 Healthcare Conference scheduled for May 13, 2025, in Las Vegas. The company aims to highlight its global healthcare mission and extensive portfolio. A live webcast of the event will be available, with an archived version accessible afterwards on their investor website. Viatris is positioned to address global healthcare needs, providing high-quality medicines to around 1 billion patients annually.
Price reaction · baseline $8.03 (2025-04-24 close) · hit after-hours · clean, no other VTRS news in the window
day 0 close · peak
+1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris will present at a major healthcare conference, highlighting its commitment to healthcare.
  • The presentation will be accessible via live webcast, increasing transparency and engagement.
  • Viatris emphasizes its global healthcare mission and extensive portfolio, showcasing its role in improving access to medicines.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH , April 25, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS ), a global healthcare company, will present at the BofA Securities 2025 Healthcare Conference in Las Vegas, NV , on Tuesday, May 13, 2025 . The company's presentation will begin at 5 p.m. PT / 8 p.m. ET .
A live webcast of the event at can be found at investor.viatris.com . An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.
About Viatris Viatris Inc. (Nasdaq: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris present at the BofA Healthcare Conference?

Viatris will present on May 13, 2025, at 5 p.m. PT / 8 p.m. ET.

Where can I watch Viatris's presentation live?

The live presentation can be viewed at investor.viatris.com.

Is there a way to access the presentation after it ends?

Yes, an archived version will be available at investor.viatris.com for a limited time.

What is Viatris's mission?

Viatris aims to empower people worldwide to live healthier at every life stage.

How many patients does Viatris serve annually?

Viatris supplies high-quality medicines to about 1 billion patients each year.

Last updated: Apr 25, 2025